Risk Factors for Encapsulating Peritoneal Sclerosis in Long-Term Peritoneal Dialysis: A Retrospective Observational Study-Reference-Cited by-同舟云学术

Risk Factors for Encapsulating Peritoneal Sclerosis in Long-Term Peritoneal Dialysis: A Retrospective Observational Study

Published:2013-04-17 Issue:1 Volume:18 Page:68-73
ISSN:1744-9979
Container-title:Therapeutic Apheresis and Dialysis
language:en
Short-container-title:Ther Apher Dial

Author:

Nakao Masatsugu¹,Yokoyama Keitaro¹,Yamamoto Izumi¹,Matsuo Nanae¹,Tanno Yudo¹,Ohkido Ichiro¹,Hayakawa Hiroshi¹,Ikeda Masato¹,Yamamoto Hiroyasu¹,Hosoya Tatsuo¹

Affiliation:

1. Department of Internal Medicine; Division of Kidney and Hypertension; The Jikei University School of Medicine; Tokyo Japan

Publisher

Wiley

Subject

Nephrology,Hematology

Reference25 articles.

1. Sclerosing peritonitis: the experience in Australia;Rigby;Nephrol Dial Transplant,1998

2. Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study;Kawanishi;Am J Kidney Dis,2004

3. Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad hoc Committee on Ultrafiltration Management in Peritoneal Dialysis;Kawaguchi;Perit Dial Int,2000

4. Serum beta2 microglobulin (beta2MG) level is a potential predictor for encapsulating peritoneal sclerosis (EPS) in peritoneal dialysis patients;Yokoyama;Clin Nephrol,2008

5. Risk factors for encapsulating peritoneal sclerosis in patients who have experienced peritoneal dialysis treatment;Yamamoto;Clin Exp Nephrol,2005

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathophysiology of encapsulating peritoneal sclerosis: lessons from findings of the past three decades in Japan;Clinical and Experimental Nephrology;2023-06-06

2. Recent Understanding and Future Directions in the Application of MMP-2 in Encapsulating Peritoneal Sclerosis Clinical Practice;Blood Purification;2023

3. C allele in transforming growth factor‐β1 rs1800471 gene polymorphisms might indicate a protective feature in encapsulating peritoneal sclerosis development;Therapeutic Apheresis and Dialysis;2022-08-24

4. Risk factors for Encapsulating Peritoneal Sclerosis in patients undergoing peritoneal dialysis: A meta-analysis;PLOS ONE;2022-03-21

5. Relationship between plasminogen activator inhibitor‐1 gene alterations and fibrosis in peritoneal dialysis patients;Therapeutic Apheresis and Dialysis;2020-06